United States v. Anesthesia Services Associates, PLLC

CourtDistrict Court, M.D. Tennessee
DecidedJuly 22, 2021
Docket3:16-cv-00549
StatusUnknown

This text of United States v. Anesthesia Services Associates, PLLC (United States v. Anesthesia Services Associates, PLLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Anesthesia Services Associates, PLLC, (M.D. Tenn. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION

UNITED STATES OF AMERICA and ) THE STATE OF TENNESSEE ex rel. ) SUZANNE ALT et al., ) ) Plaintiffs, ) ) v. ) Case No. 3:16-cv-0549 ) Judge Aleta A. Trauger ANESTHESIA SERVICES ) ASSOCIATES, PLLC, d/b/a ) COMPREHENSIVE PAIN ) SPECIALISTS, et al., ) ) Defendants. )

MEMORANDUM Before the court is the Joint Motion to Allocate Relator Share and Attorney Fee and Expenses (“Motion to Allocate”) (Doc. No. 184), filed along with a Memorandum in Support thereof (Doc. No. 185) by relators Suzanne Alt, Mary Butner, Dana Brown, and Jennifer Pressotto (the “Moving Relators”). Relator Allison Chancellor has filed a series of responses to the motion, the last of which is styled as her Second Amended Memorandum in Opposition to the Moving Parties’ Joint Motion to Allocate Relator Share and Attorney Fees and Expenses (Doc. No. 193), which the court understands to supersede Chancellor’s previous filings in response to the Motion to Allocate. The Moving Relators filed a Reply. (Doc. No. 194.) In addition, Chancellor has filed a pro se Motion to Be Deemed First-to-File Regarding Specimen Validity (“SVT”), Psychological (“iPAD”), and Pharmacogenetic (“Genetic”) Testing (and Urine Drug Testing if the Court Determines Chancellor is First-to-File) as to the United States’ and Tennessee’s Settlement with CPS (Doc. No. 195), along with a supporting memorandum (Doc. No. 196), which, if granted, would affect the allocation of proceeds of the settlement reserved for the relators.1 For the reasons set forth herein, the Moving Relators’ Motion to Allocate will be granted in part and denied in part, and Chancellor’s Motion to Be Deemed First to File will be denied. I. PROCEDURAL BACKGROUND

Relator Suzanne Alt filed her whistleblower complaint against defendant Anesthesia Associates, PLLC d/b/a Comprehensive Pain Specialists (“CPS”) on March 9, 2016; relators Butner and Brown jointly filed their whistleblower complaint on March 11, 2016; relator Pressotto filed the third complaint on July 18, 2016; and relator Chancellor filed her whistleblower complaint in the Southern District of Illinois on October 27, 2016.2 Chancellor’s case was eventually transferred to the Middle District of Tennessee and consolidated with the other pending qui tam cases. The United States and the State of Tennessee (collectively, “the Government”) filed a Notice of Election to Intervene, and Decline to Intervene, in Parts of this Consolidated Action (Doc. No. 43), and a Complaint in Intervention was filed on July 19, 2019 (Doc. No. 65). By then, it was apparently already clear that the funds available to pay any settlement or judgment would be far

less than the Government’s damages, as CPS had ceased operations. In April 2020, the court granted the parties’ joint motion to extend all deadlines while the parties engaged in mediation and settlement discussions. As of July 2020, the parties had agreed to the basic terms of a settlement agreement with CPS for $2,196,663.94 (the “Suspended

1 Chancellor was represented by counsel until January 19, 2021, when the court granted her attorneys’ Amended Motion to Withdraw. (Doc. No. 174.) Having been unable to procure successor counsel, she has proceeded pro se since that time. 2 A fifth whistleblower complaint was filed on May 2, 2017, making allegations that had already been made by the previous relators. That case was voluntarily dismissed on August 24, 2020 (Doc. No. 162), and the relators who filed that case were not included in the ultimate settlement of the consolidated case. Amount”), the value of the funds then held by the Government in a payment suspension account, with an additional $138,000 to be contributed to the settlement pool by CPS for the relators’ non- intervened claims and attorney’s fees. (See Doc. No. 166-1, at 6, 5). According to the Settlement Agreement executed by all of the parties,3 CPS ultimately agreed to pay the total settlement amount of $2,964,663.93.4 (Settlement Agreement ¶ 1.) Defendant Peter Kroll separately agreed to pay

$150,000 (the “Kroll Settlement Amount”). (Id. ¶ 2.) A proposed version of the Settlement Agreement that was not actually adopted by the parties (“Proposed Settlement”) indicates that the total Relators’ Share ($610,684.62) is made up of $589,332.79 from the CPS Settlement Amount,5 to be divided among all of the relators, plus an additional $21,351.83 from the Kroll Settlement Amount, to be paid to relators Butner and Brown.6 (See Doc. No. 175-1 ¶ 3 n.2.) The Proposed Settlement anticipated that the Relators’ Share would be allocated as follows: Alt to receive $212,832.59; Butner and Brown together to receive $30,585.57, plus $21,351.83 from the Kroll Settlement Amount; Pressotto to receive $31,951.74; and Chancellor to receive $313,952.89. (Doc. No. 175-1, at 18 ¶ 3 n.2.) These allocations were

based on the Government’s estimates of potential damages attributable to each of the different claims in which it had intervened and a pro rata allocation of the Relators’ Share to each of the relators with respect to the settled claims for which they were deemed the “first to file.” (See Doc.

3 A copy of the final, fully executed Settlement Agreement was emailed to the court on April 16, 2021, but it has never actually been filed in the court’s docket. 4 This figure likely contains a typographical error. It appears that the parties intended to settle for $2,946,663.94, or the sum of $2,196,663.94 and $750,000 (see Settlement Agreement ¶ 1(a) and (b)), rather than $2,964,663.94. 5 This figure represents twenty percent of $2,946,663.94. 6 According to the Moving Relators, the Government determined that “[a]ny Relator share payment out of the Kroll Settlement amount was properly payable to Butner and Brown” (Doc. No. 185, at 6 n.2), as they were the only relators to name Kroll as a defendant. No. 185, at 5–6.) The charts that the Government apparently provided to the relators, and which the relators have supplied to the court in their respective motions, reflect the Government’s assessment of the total value of each of the intervened and settled claims, whom the Government deemed the “first to file” each claim, and the portion of the settlement traceable to each claim, as follows:

Claim7 US Damages TN Damages US + TN Combined UDS $3,000,000 $300,000 $3,300,000 iPad $2,400,000 $1,000,000 $3,400,000 Genetic $2,000,000 $500,000 $2,500,000 SVT $1,000,000 $275,000 $1,275,000 P-Stim $150,000 $450,000 $600,000 $8,550,000 $2,525,000 $11,075,000

Claim US Damages % TN Damages % UDS 35.09% 11.88% iPad 28.07% 39.60% Genetic 23.39% 19.80% SVT 11.70% 10.89% P-Stim 1.75% 17.82% 100% 100%

Settlement from CPS $2,946,663.94 CPS US Portion 77.20% CPS TN Portion 22.80% CPS US &TN Relators’ % 20.00% CPS US Relators’ Share $454,964.91 CPS TN Relators’ Share $134,367.88 Total Relators’ Share $589,332.79

7 “UDS” refers to Urine Drug Screening; “iPad” refers to a depression screening test conducted on iPads; “Genetic” refers to various pharmacogenetic blood tests; “SVT” stands for Specimen Validity Testing; and “P-Stim” refers to a non-covered acupuncture device. Relator First-To-File on US TN Estimated US Estimated Estimated Settled Claims Damages Damages Relator’s TN Total % % Share Relator's Relator’s Share Share Alt US: UDS/SVT 46.78% 0.00% $212,832.59 $212,832.59 Butner/Brow TN: UDS/SVT 0.00% 22.77% $30,595.57 $30,595.57 n Pressotto US: P-Stim 1.76% 17.82% $8,007.38 $23,944.36 $31,951.74 TN: P-Stim Chancellor US: iPad, 51.46% 59.41% $234,124.94 $79,827.95 $313,952.89 Genetic TN: iPad, Genetic 100.00% 100.00% $454,964.91 $134,367.88 $589,332.79

(See Doc. No. 196, at 27; see also Doc. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rocio Henriquez-Rivas v. Eric Holder, Jr.
707 F.3d 1081 (Ninth Circuit, 2013)
United States Ex Rel. Dhillon v. Endo Pharmaceuticals
617 F. App'x 208 (Third Circuit, 2015)
Rille v. PricewaterhouseCoopers LLP
803 F.3d 368 (Eighth Circuit, 2015)
United States Ex Rel. Shea v. Cellco Partnership
863 F.3d 923 (D.C. Circuit, 2017)
McGuire v. Estate of Robert Cunningham
923 F.3d 240 (First Circuit, 2019)
United States ex rel. Heath v. AT & T, Inc.
791 F.3d 112 (D.C. Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Anesthesia Services Associates, PLLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-anesthesia-services-associates-pllc-tnmd-2021.